Novel BRCA2 c.8434_8435insTT (p. Gly2812Valfs*10) mutation in a family with multiple hematologic malignancies and solid tumors
Authors:
- 21 December 2020
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 62 (5) , 1275-1277
Abstract
Hereditary breast cancer is caused by autosomal dominant germline mutations in human breast cancer genes, mainly BRCA1 and BRCA2. BRCA mutations are associated with increased risk of breast and ova...Keywords
This publication has 8 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort StudyBritish Journal of Cancer, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrierNature, 2014
- Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLCBiochemical and Biophysical Research Communications, 2006
- Cancer Incidence in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2002
- Cancer Risks in BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 1999
- BRCA2 germline mutations in male breast cancer cases and breast cancer familiesNature Genetics, 1996